Comparison of two once daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral-therapy-naive adults: 48 weeks results from the Antiretroviral Regimen Evaluation Study (ARES)

S.H. Lowe; A.M.J. Wensing; E. Hassink; R.W. ten Kate; C. Richter; G. Schreij; P.P. Koopmans; J.R. Juttmann; I. van der Tweel; J.M.A. Lange; J.C.C. Borleffs

Comparison of two once daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral-therapy-naive adults: 48 weeks results from the Antiretroviral Regimen Evaluation Study (ARES)

Translated title of the contribution: Comparison of two once daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral-therapy-naive adults: 48 weeks results from the Antiretroviral Regimen Evaluation Study (ARES)

S.H. Lowe, A.M.J. Wensing, E. Hassink, R.W. ten Kate, C. Richter, G. Schreij, P.P. Koopmans, J.R. Juttmann, I. van der Tweel, J.M.A. Lange, J.C.C. Borleffs

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Comparison of two once daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral-therapy-naive adults: 48 weeks results from the Antiretroviral Regimen Evaluation Study (ARES)
Original language	Undefined/Unknown
Pages (from-to)	235-245
Number of pages	11
Journal	HIV Clinical Trials
Volume	6
Publication status	Published - 2005

Cite this

Lowe, S. H., Wensing, A. M. J., Hassink, E., ten Kate, R. W., Richter, C., Schreij, G., Koopmans, P. P., Juttmann, J. R., van der Tweel, I., Lange, J. M. A., & Borleffs, J. C. C. (2005). Comparison of two once daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral-therapy-naive adults: 48 weeks results from the Antiretroviral Regimen Evaluation Study (ARES). HIV Clinical Trials, 6, 235-245.

@article{ac73450dee7b4f93bc9e6ef52e30c1c6,

title = "Comparison of two once daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral-therapy-naive adults: 48 weeks results from the Antiretroviral Regimen Evaluation Study (ARES)",

author = "S.H. Lowe and A.M.J. Wensing and E. Hassink and {ten Kate}, R.W. and C. Richter and G. Schreij and P.P. Koopmans and J.R. Juttmann and {van der Tweel}, I. and J.M.A. Lange and J.C.C. Borleffs",

year = "2005",

language = "Undefined/Unknown",

volume = "6",

pages = "235--245",

journal = "HIV Clinical Trials",

issn = "1528-4336",

publisher = "Taylor and Francis Ltd.",

}

Lowe, SH, Wensing, AMJ, Hassink, E, ten Kate, RW, Richter, C, Schreij, G, Koopmans, PP, Juttmann, JR, van der Tweel, I, Lange, JMA & Borleffs, JCC 2005, 'Comparison of two once daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral-therapy-naive adults: 48 weeks results from the Antiretroviral Regimen Evaluation Study (ARES)', HIV Clinical Trials, vol. 6, pp. 235-245.

Comparison of two once daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral-therapy-naive adults: 48 weeks results from the Antiretroviral Regimen Evaluation Study (ARES). / Lowe, S.H.; Wensing, A.M.J.; Hassink, E. et al.
In: HIV Clinical Trials, Vol. 6, 2005, p. 235-245.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Comparison of two once daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral-therapy-naive adults: 48 weeks results from the Antiretroviral Regimen Evaluation Study (ARES)

AU - Lowe, S.H.

AU - Wensing, A.M.J.

AU - Hassink, E.

AU - ten Kate, R.W.

AU - Richter, C.

AU - Schreij, G.

AU - Koopmans, P.P.

AU - Juttmann, J.R.

AU - van der Tweel, I.

AU - Lange, J.M.A.

AU - Borleffs, J.C.C.

PY - 2005

Y1 - 2005

M3 - Article

SN - 1528-4336

VL - 6

SP - 235

EP - 245

JO - HIV Clinical Trials

JF - HIV Clinical Trials

ER -